XRP News Today: Institutions Fuel Crypto-Stock Surge, AI Giants Drive Market Rally

The cryptocurrency and stock markets are experiencing a surge as investors flock to high-growth assets amid a broader bull run. XRP, the native token of Ripple, has surged over 88% from its monthly low to $2.6197, driven by robust institutional demand for its futures contracts and a newly launched spot ETF. The REX-Osprey XRP ETF has amassed $100 million in assets within a month, while CME Group's XRP futures open interest hit $9.9 billion—the highest since September—indicating strong retail and institutional participation, according to a crypto.news report.

Meanwhile, crypto exchange Bullish is prepping for a $4.8 billion valuation in an upsized IPO, backed by $200 million in commitments from BlackRock and Ark Invest. The company, which trades under the ticker "BLSH," reported a net income of $106–$109 million in Q2 2025 after posting losses in Q1 and Q4 2024, signaling a turnaround amid rising crypto prices and regulatory clarity, according to a CoinDesk report.

In the stock market, Palantir Technologies (PLTR) has become a standout performer, surging 300% in 2025 to a record $190 per share and a $400 billion market cap. The AI-driven data analytics firm has landed a string of mega-deals, including a $10 billion U.S. Army contract and partnerships with Boeing, Snowflake, and Lumen Technologies. These wins, coupled with Q2 revenue of $1.03 billion (up 48% year-over-year), have solidified Palantir's role as a key player in the AI arms race, as noted in a TS2 Tech analysis.

Snowflake, another AI infrastructure leader, is also attracting attention. Its AI Data Cloud platform, now integrated with Palantir's systems, has driven $4.6 billion in projected 2026 revenue. Analysts at Wedbush argue Snowflake is in the "early innings of AI demand," with its shares trading at a 20.4x sales multiple—justified by its expanding enterprise AI partnerships and growing data interoperability .

However, not all news is bullish. MoonLake Immunotherapeutics (MLTX) faces a class-action lawsuit deadline on December 15 after its stock plummeted 90% following a September 2025 earnings miss. Investors are advised to consult legal counsel, as the firm's recent $55.75-per-share drop raises concerns about governance and financial reporting, according to a GlobeNewswire notice.

The market's optimism is further fueled by rising open interest in XRP futures and the success of Brazil's Hashdex Nasdaq XRP ETF, which has added $52 million in assets. Ripple's RLUSD stablecoin, nearing $1 billion in assets, and Evernorth's commitment to hold XRP as a core reserve asset underscore growing institutional confidence in the token .